BPH Global Ltd (BP8, formerly Stemcell United Limited) is a plant-focused biotechnology company with focus on producing foods and products which deliver Traditional Chinese Medicine-based health outcomes. It focuses on the research & development, production and commercialisation of traditional medicine products, including birds' nests, seaweeds and sea plants and hemp. The Company's key markets are China, Singapore, Australia and Southeast Asia.
Latest Posts
Line Chart with Gradient
Price
$0.004
0.001 (33.33%)
At Close 21/11 (AEST)
Input ticker not found.
Leave a Comment on BP8
Thank you! Your comment has been submitted for review.